Clinical Trial Update: Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

View source ↗

Summary

Tempus CRC Surveillance Study is a ctDNA biomarker profiling study in colorectal cancer patients using next-generation sequencing assays. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Tempus AI | Conditions: Colorectal Cancer | Status: RECRUITING